Annual Total Long Term Liabilities
$254.90 M
+$6.78 M+2.73%
December 31, 2023
Summary
- As of March 11, 2025, ARTV annual total long term liabilities is $254.90 million, with the most recent change of +$6.78 million (+2.73%) on December 31, 2023.
- During the last 3 years, ARTV annual total long term liabilities has risen by +$209.87 million (+465.98%).
- ARTV annual total long term liabilities is now at all-time high.
Performance
ARTV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$11.31 M
-$244.87 M-95.59%
September 30, 2024
Summary
- As of March 11, 2025, ARTV quarterly total long term liabilities is $11.31 million, with the most recent change of -$244.87 million (-95.59%) on September 30, 2024.
- Over the past year, ARTV quarterly long term liabilities has stayed the same.
- ARTV quarterly long term liabilities is now -95.59% below its all-time high of $256.18 million, reached on June 30, 2024.
Performance
ARTV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ARTV Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.7% | 0.0% |
| 3 y3 years | +466.0% | 0.0% |
| 5 y5 years | +3144.3% | 0.0% |
ARTV Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.4% | -95.6% | at low |
| 5 y | 5-year | at high | +3144.3% | -95.6% | at low |
| alltime | all time | at high | +3144.3% | -95.6% | at low |
Artiva Biotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.31 M(-95.6%) |
| Jun 2024 | - | $256.18 M(+0.7%) |
| Mar 2024 | - | $254.47 M(-0.2%) |
| Dec 2023 | $254.90 M(+2.7%) | $254.90 M(+6.8%) |
| Dec 2022 | $248.13 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $238.62 M(-0.4%) |
| Dec 2021 | $239.48 M(+431.7%) | $239.48 M(-1.0%) |
| Sep 2021 | - | $241.83 M(+437.0%) |
| Dec 2020 | $45.04 M(+473.2%) | $45.04 M |
| Dec 2019 | $7.86 M | - |
FAQ
- What is Artiva Biotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics annual total long term liabilities year-on-year change?
- What is Artiva Biotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics quarterly long term liabilities year-on-year change?
What is Artiva Biotherapeutics annual total long term liabilities?
The current annual total long term liabilities of ARTV is $254.90 M
What is the all time high annual total long term liabilities for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high annual total long term liabilities is $254.90 M
What is Artiva Biotherapeutics annual total long term liabilities year-on-year change?
Over the past year, ARTV annual total long term liabilities has changed by +$6.78 M (+2.73%)
What is Artiva Biotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ARTV is $11.31 M
What is the all time high quarterly long term liabilities for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high quarterly total long term liabilities is $256.18 M
What is Artiva Biotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, ARTV quarterly total long term liabilities has changed by $0.00 (0.00%)